Stevens GH - Search Results

1

Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.

Galor A, Ference SJ, Singh AD, Lee MS, Stevens GH, Perez VL, Peereboom DM. Galor A, et al. Among authors: stevens gh. Am J Ophthalmol. 2007 Jul;144(1):45-49. doi: 10.1016/j.ajo.2007.03.057. Am J Ophthalmol. 2007. PMID: 17601426

2

Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis.

Nussenblatt RB, Palestine AG, Chan CC, Stevens G Jr, Mellow SD, Green SB. Nussenblatt RB, et al. Am J Ophthalmol. 1991 Aug 15;112(2):138-46. doi: 10.1016/s0002-9394(14)76692-9. Am J Ophthalmol. 1991. PMID: 1867297 Clinical Trial.

3

Gliomatosis cerebri: treatment results with radiotherapy alone.

Elshaikh MA, Stevens GH, Peereboom DM, Cohen BH, Prayson RA, Lee SY, Barnett GH, Suh JH. Elshaikh MA, et al. Among authors: stevens gh. Cancer. 2002 Nov 1;95(9):2027-31. doi: 10.1002/cncr.10909. Cancer. 2002. PMID: 12404298 Free article. Review.

4

Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.

Hercbergs AA, Goyal LK, Suh JH, Lee S, Reddy CA, Cohen BH, Stevens GH, Reddy SK, Peereboom DM, Elson PJ, Gupta MK, Barnett GH. Hercbergs AA, et al. Among authors: stevens gh. Anticancer Res. 2003 Jan-Feb;23(1B):617-26. Anticancer Res. 2003. PMID: 12680157 Clinical Trial.

5

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.

Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, Stevens GH, Masaryk T, Aumayr B, Vogelbaum MA, Barnett GH, Janigro D. Kanner AA, et al. Among authors: stevens gh. Cancer. 2003 Jun 1;97(11):2806-13. doi: 10.1002/cncr.11409. Cancer. 2003. PMID: 12767094 Free PMC article.

6

New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.

Doolittle ND, Abrey LE, Bleyer WA, Brem S, Davis TP, Dore-Duffy P, Drewes LR, Hall WA, Hoffman JM, Korfel A, Martuza R, Muldoon LL, Peereboom D, Peterson DR, Rabkin SD, Smith Q, Stevens GH, Neuwelt EA. Doolittle ND, et al. Among authors: stevens gh. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):421-8. Clin Cancer Res. 2005. PMID: 15701824

7

Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.

Quan AL, Barnett GH, Lee SY, Vogelbaum MA, Toms SA, Staugaitis SM, Prayson RA, Peereboom DM, Stevens GH, Cohen BH, Suh JH. Quan AL, et al. Among authors: stevens gh. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):695-703. doi: 10.1016/j.ijrobp.2005.03.051. Epub 2005 Jun 2. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936158

8

The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making.

Kanner AA, Staugaitis SM, Castilla EA, Chernova O, Prayson RA, Vogelbaum MA, Stevens G, Peereboom D, Suh J, Lee SY, Tubbs RR, Barnett GH. Kanner AA, et al. Among authors: stevens g. J Neurosurg. 2006 Apr;104(4):542-50. doi: 10.3171/jns.2006.104.4.542. J Neurosurg. 2006. PMID: 16619658

9

Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.

Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, Peereboom DM, Stevens G, McGregor J, Jahnke K, Lacy CA, Hedrick NA, Shalom E, Ference S, Bell S, Sorenson L, Tyson RM, Haluska M, Neuwelt EA. Angelov L, et al. Among authors: stevens g. J Clin Oncol. 2009 Jul 20;27(21):3503-9. doi: 10.1200/JCO.2008.19.3789. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451444 Free PMC article.

10

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.

Peereboom DM, Shepard DR, Ahluwalia MS, Brewer CJ, Agarwal N, Stevens GH, Suh JH, Toms SA, Vogelbaum MA, Weil RJ, Elson P, Barnett GH. Peereboom DM, et al. Among authors: stevens gh. J Neurooncol. 2010 May;98(1):93-9. doi: 10.1007/s11060-009-0067-2. Epub 2009 Dec 4. J Neurooncol. 2010. PMID: 19960228 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page